Sleep Initiation and Maintenance Disorders Clinical Trial
Official title:
Grain Moxibustion Treatment on Insomnia: a Randomized Controlled Trial
This trial intends to observe the clinical efficacy and safety of grain moxibustion at Baihui(GV20), Xinshu(BL15) and Pishu(BL20) in the treatment of insomnia.
Insomnia is one of the most common sleep disorders. The main symptoms are difficulty in falling asleep, decreased sleep quality and sleep time, and affect the normal work, study and life during the day. Acupuncture has a good clinical effect on insomnia, but most of the treatment methods are acupuncture or electroacupuncture. Moxibustion therapy, as one of the main components of the therapy, has the advantages of simple operation, wide acceptance, which is suitable for a wide range of promotion and application.At present, the trials of moxibustion in the treatment of insomnia mainly focus on mild moxibustion. The number of studies is small, and the research is designed insufficiently, so it is difficult to draw a positive conclusion, and needs to be further confirmed by rigorous designed experiments. In addition, grain moxibustion, which is widely used in clinic, has the advantages of more convenient operation, short treatment time and strong permeability. However, its efficacy and safety in the treatment of insomnia are still unclear, so it is necessary to carry out a randomized controlled trial to confirm it. One hundred and two eligible patients will be randomly assigned to one of 3 groups: grain moxibustion group, sham grain moxibustion group and wait-list control group. Treatment will be given 3 times per week for 4 weeks. The primary outcome is the Pittsburgh Sleep Quality Index (PSQI). The secondary outcomes are changes of PSQI scores from baseline to 8 week follow-up, sleep monitoring of bracelet, Athens Insomnia Scale(AIS), Generalized Anxiety Disorder Scale-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9) and recurrence observation during the follow-up period. Daily dose of patients' estazolam will be recorded in the dairy. All adverse effects will be assessed by the Treatment Emergent Symptom Scale (TESS). Outcomes will be evaluated at baseline, 4 weeks post-treatment, as well as at 8 week and 12 week follow-up. This trial intends to observe the clinical efficacy and safety of grain moxibustion at Baihui(GV20), Xinshu(BL15) and Pishu(BL20) in the treatment of insomnia, which will provide an experimental basis for the treatment of insomnia with grain moxibustion and lay the foundation for the promotion and application of moxibustion in the future. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Recruiting |
NCT05000528 -
Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia
|
N/A | |
Completed |
NCT04661306 -
The Better Sleep for Supporters With Insomnia Study
|
N/A | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Completed |
NCT01784614 -
A Study of LY2624803 in Japanese Participants With Transient Insomnia
|
Phase 1 | |
Completed |
NCT00380003 -
Efficacy Study of EVT 201 to Treat Insomnia
|
Phase 2 | |
Completed |
NCT00365261 -
Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer
|
Phase 4 | |
Completed |
NCT00183378 -
Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease
|
N/A | |
Completed |
NCT00946530 -
Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease
|
N/A | |
Completed |
NCT00097604 -
Effects of Valerian on Sleep in Healthy Older Adults
|
Phase 2 | |
Completed |
NCT00630175 -
Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia
|
Phase 3 | |
Completed |
NCT00044629 -
Combined Behavioral/Pharmacological Therapy for Insomnia
|
Phase 2 | |
Completed |
NCT00079664 -
Comparing Tai Chi Training to a Low-Stress Physical Activity to Enhance Sleep in Older Adults
|
Phase 1 | |
Completed |
NCT01154023 -
Behavioral Intervention for Insomnia in Older Adults
|
N/A | |
Recruiting |
NCT04417153 -
Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes
|
||
Completed |
NCT04560595 -
Remote Guided Caffeine Reduction
|
N/A | |
Enrolling by invitation |
NCT04986007 -
Addressing Nocturnal Sleep/Wake Effects on Risk of Suicide in Older Adults
|
N/A | |
Completed |
NCT03852966 -
Better Sleep in Psychiatric Care - ADHD Pilot Study
|
N/A | |
Terminated |
NCT00750919 -
Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
|
Phase 3 | |
Recruiting |
NCT04550507 -
Mind-Body Interventions to Mitigate Effects of Media Use on Sleep in Early Adolescents
|
N/A |